| Literature DB >> 28850582 |
Kosuke Ebina1, Makoto Hirao1, Keishi Takagi2, Sachi Ueno2, Tokimitsu Morimoto3, Hozo Matsuoka1, Kazuma Kitaguchi1, Toru Iwahashi1, Jun Hashimoto4, Hideki Yoshikawa1.
Abstract
PURPOSE: The purpose of this retrospective study is to clarify the difference in plantar pressure distribution during walking and related patient-based outcomes between forefoot joint-preserving arthroplasty and resection-replacement arthroplasty in patients with rheumatoid arthritis (RA).Entities:
Mesh:
Year: 2017 PMID: 28850582 PMCID: PMC5574579 DOI: 10.1371/journal.pone.0183805
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Plantar peak pressure distribution (%) of the region of interest matched with patients’ standing feet X-rays, and representative radiographs and plantar peak pressure distribution of each group.
(a) Walking peak plantar pressure distribution of the 1st MTP joint, 2nd-3rd MTP joint, 4th-5th MTP joint and the heel evaluated by the F-SCAN II system. (b) The healthy control, deformed-RA, metatarsal head resection-replacement arthroplasty (Swanson implant replacement of the hallux metatarsophalangeal joint and metatarsal head resection of the lesser toes), and metatarsophalangeal joint-preserving arthroplasty (modified Scarf osteotomy with inter-positioning technique of the medical capsule of the hallux and off-set shortening osteotomy of the lesser toes) groups were evaluated.
Clinical characteristics and radiographic evaluation of each group.
| Variable | Control (n = 22) | Deformed-RA (n = 36) | Resection-replacement (n = 27) | Joint-preserving (n = 34) | |||
|---|---|---|---|---|---|---|---|
| Operation methods (n) | Hallux | - | Swanson implant (n = 26) | Modified Scarf (n = 29) | |||
| Metatarsal head resection (n = 1) | Modified Mann (n = 4) | ||||||
| Lapidus (n = 1) | |||||||
| Lesser toes | - | Metatarsal head resection (n = 27) | Off-set osteotomy (n = 34) | ||||
| Pre-op / Post-op (at evaluation) | - | - | Pre-op | Post-op (at evaluation) | Pre-op | Post-op (at evaluation) | |
| Post-op duration (years) | - | - | - | 5.6±0.8 | - | 3.2±0.5 | |
| Age, (years) | 48.6±3.8 | 64.8±2.0 | 54.8±1.3 | 60.7±1.5 | 61.2±1.6 | 64.6±1.7 | |
| Gender, Females (%; n/N) | 54.5 (12/22) | 91.7 (33/36) | 100 (27/27) | 88.2 (30/34) | |||
| Body mass index (kg/m2) | 21.6±0.6 | 21.0±0.6 | 20.7±0.7 | 20.3±0.6 | 21.7±0.6 | 21.9±0.6 | |
| Duration of disease (years) | - | 20.7±2.0 | 20.3±1.4 | 26.0±1.5 | 19.0±2.1 | 22.4±2.0 | |
| Steinbrocker’ s stage (n) | - | Ⅲ(n = 4) Ⅳ(n = 32) | Ⅲ(n = 1) Ⅳ(n = 26) | Ⅲ(n = 5) Ⅳ(n = 29) | |||
| Steinbrocker’ s functional class (n) | - | Ⅱ(n = 12) Ⅲ(n = 24) | Ⅱ(n = 12) Ⅲ(n = 14) Ⅳ(n = 1) | Ⅱ(n = 18) Ⅲ(n = 16) | |||
| RF positivity (%) | - | 86.1 (31/36) | 85.2 (23/27) | 88.9 (24/27) | 82.4 (28/34) | 79.4 (27/34) | |
| DAS28-CRP | - | 2.3±0.1 | 2.6±0.1 | 2.4±0.2 | 2.4 ± 0.1 | 2 .3±0.1 | |
| Prednisolone dose (mg/day) | - | 0.7±0.2 | 2.8±0.5 | 3.0±0.8 | 1.0±0.4 | 0.6±0.2 | |
| Prednisolone usage (%) | - | 22.2 (8/36) | 51.9 (14/27) | 55.6 (15/27) | 29.4 (10/34) | 23.5 (8/34) | |
| MTX dose (mg/week) | - | 3.8±0.6 | 3.6±0.8 | 3.9±0.7 | 4.4±0.6 | 4.6±0.7 | |
| MTX usage (%) | - | 63.9 (23/36) | 51.9 (14/27) | 55.6 (15/27) | 73.5 (25/34) | 70.6 (24/34) | |
| Biologics usage (%) | - | 47.2 (17/36) | 18.5 (5/27) | 22.2 (6/27) | 38.2 (13/34) | 41.2 (14/34) | |
| Biologics (n) | - | TCZ(9) ETN(4) ABT(4) | TCZ(2) ETN(2) IFX(1) | TCZ(3) ETN(2) IFX(1) | TCZ(8) ETN(2) ABT(3) | TCZ(9) ETN(2) ABT(3) | |
| Prior lower limb operation (n) | - | THA (n = 3) TKA (n = 9) | THA (n = 2) TKA (n = 6) | THA (n = 3) TKA (n = 8) | THA (n = 2) TKA (n = 4) | THA (n = 2) TKA (n = 5) | |
| TAA (n = 1) | Knee synovectomy (n = 2) | Knee synovectomy (n = 2) | TAA (n = 2) | TAA (n = 3) | |||
| Subtalar arthrodesis (n = 1) | Subtalar arthrodesis (n = 1) | ||||||
| Leg-heel angle (degree) | - | 3.0±1.1 | - | 2.7±1.7 | - | 2.5±1.1 | |
| HV angle (degree) | - | 39.2±3.7 | 37.6 ± 3.3 | 19.0±2.0 | 40.2 ± 2.8 | 11.5±1.8 | |
| M1M2 angle (degree) | - | 13.0±0.7 | 11.4 ± 1.0 | 7.6±0.9 | 13.6 ± 0.7 | 8.2±0.7 | |
| M1M5 angle (degree) | - | 33.2±1.4 | 34.6 ± 1.3 | 30.7±1.3 | 35.7 ± 1.0 | 23.1±0.9 | |
Mean ± Standard Error (SE), unless otherwise noted. N.S., not significant.
Pre-op, Pre-operation; Post-op, Post-operation; RF, Rheumatoid factor; DAS28-CRP, Disease activity score assessing 28 joints with CRP; MTX, Methotrexate; TCZ, tocilizumab; ETN, etanercept
ABT, abatacept; IFX, infliximab; THA, Total hip arthroplasty; TKA, Total knee arthroplasty; TAA, Total ankle arthroplasty; HV, Hallux valgus; M1M2, first metatarsal and second metatarsal; M1M5, first metatarsal and fifth metatarsal.
Differences between the groups were determined by ANOVA, the Mann-Whitney U-test, or the chi-squared test.
* P<0.05
** P<0.01
*** P<0.001; Resection-replacement vs Joint-preserving group
# P<0.05
### P<0.001; Deformed-RA vs Resection-replacement group
††† P<0.001; Deformed-RA vs Joint-preserving group
Fig 2Mean SAFE-Q subscale scores and plantar peak pressure distribution (%) of each group.
(a) Pain and pain-related scores, physical functioning and daily-living scores, social functioning scores, general health and well-being scores, and shoe-related scores were evaluated (full score 100 points). (b) 1st MTP joint, 2nd-3rd MTP joint, 4th-5th MTP joint, and heel distributions were evaluated. Bars indicate standard errors. * P < 0.05, ** P < 0.01, and *** P < 0.001 between the groups.
Fig 3Representative pre-operative and post-operative radiographs and plantar peak pressure distributions of each group.
(a) Metatarsal head resection-replacement arthroplasty and (b) metatarsophalangeal joint-preserving arthroplasty.
Fig 4Longitudinal changes in the plantar peak pressure distribution (%) between pre-operation and post-operation of each group.
(a) Metatarsal head resection-replacement arthroplasty and (b) metatarsophalangeal joint-preserving arthroplasty. The bold line and number indicate mean values. N.S. (not significant), ** P < 0.01, and *** P < 0.001 pre-operation vs post-operation.